Development of novel ligands for peptide GPCRs
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference54 articles.
1. A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology;Padberg;PLoS ONE,2014
2. Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes;Fu;Curr Diabet Rev,2013
3. G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homeostasis;Moran;Acta Diabetol,2016
4. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes;Ahren;Nat Rev Drug Discov,2009
5. New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders;Irwin;World J Diabetes,2015
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GPCRs involved in metabolic diseases: pharmacotherapeutic development updates;Acta Pharmacologica Sinica;2024-02-07
2. Comprehensive Search for GPCR Compounds which Can Enhance MafA and/or PDX-1 Expression Levels Using a Small Molecule Compound Library;Journal of Diabetes Research;2023-09-08
3. GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process;International Journal of Molecular Sciences;2023-05-09
4. BRSK2 in pancreatic β cells promotes hyperinsulinemia-coupled insulin resistance and its genetic variants are associated with human type 2 diabetes;Journal of Molecular Cell Biology;2023-05
5. GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation;Peptides;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3